Kimberly Hartig

701 citations
4 papers · 213 indexed · h-index 3
Topics
Lymphoma Diagnosis and Treatment (4 papers)Sarcoma Diagnosis and Treatment (3 papers)Viral-associated cancers and disorders (2 papers)
Partner nations
United StatesPuerto Rico

In The Last Decade

Kimberly Hartig

4 papers receiving 210 citations

Peers

Kimberly Hartig
Comparison fields: 5 of 20
  • Pathology and Forensic Medicine 200
  • Oncology 151
  • Genetics 109
  • Pulmonary and Respiratory Medicine 41
  • Neurology 21
Replace Olaf Determann with:
Olaf Determann Germany
Michał Szymczyk Poland
Rory McCulloch United Kingdom
Chiara Lobetti‐Bodoni Switzerland
Mitul Gandhi United States
Armando López Guillermo Spain
Joan E. Ramis-Zaldivar Spain
Sherri Cicero United States
Susan Blumel United States
Henriette W Berenschot Netherlands
Kimberly Hartig relative to Olaf Determann Germany Olaf Determann's profile →
Citations per field
00.5×1.6×
Olaf Determann · 1×
Citations per year

Countries citing papers authored by Kimberly Hartig

Since Specialization
Citations

This map shows the geographic impact of Kimberly Hartig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Hartig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Hartig more than expected).

Fields of papers citing papers by Kimberly Hartig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Hartig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Hartig. The network helps show where Kimberly Hartig may publish in the future.

Co-authorship network of co-authors of Kimberly Hartig

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Hartig. A scholar is included among the top collaborators of Kimberly Hartig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Hartig. Kimberly Hartig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 1
2 36
3 170
4 6

About Kimberly Hartig

Kimberly Hartig is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 4 papers that have together received 213 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (200 citations), Genetics (109 citations) and Oncology (151 citations). Kimberly Hartig has collaborated with scholars based in United States and Puerto Rico. Frequent co-authors include Michael Wang, Luis Fayad, Barbara Pro, Larry W. Kwak, Peter McLaughlin, André Goy, Jorge Romaguera, Felipe Samaniego, Maria Alma Rodriguez and Fernando Cabanillas. Their work appears in journals such as Blood and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026